Business UpdateJun 11, 2026, 07:01 AM
Medifast's OPTAVIA Targets Midlife Women's Metabolic Health
AI Summary
Medifast's OPTAVIA announced its program effectively addresses metabolic shifts in women during perimenopause and menopause, focusing on visceral fat reduction and lean mass preservation. Clinical research shows the Optimal Weight 5 & 1 Plan reduces visceral fat by 14% in 16 weeks and retains 98% lean mass. The company emphasizes the critical role of coaching, with coached participants losing significantly more weight and fat.
Key Highlights
- OPTAVIA's Optimal Weight 5 & 1 Plan reduces visceral fat by 14% in 16 weeks.
- The plan enables participants to retain 98% of lean mass during weight loss.
- Coached participants lose up to 10 times more weight and 17 times more fat.
- OPTAVIA's clinical approach is supported by 18 randomized controlled trials.
- The company's research portfolio includes over 30 studies and 40 peer-reviewed publications.
- Program targets metabolic shifts in women during perimenopause and menopause.
Price Impact
More from MED